Dianthus Therapeutics targets severe autoimmune diseases with DNTH103. Read more on DNTH's promise amid competitive ...

As a result, the muscles become weak when a person performs repeated physical movements. The disease is neither contagious nor inherited but it is often misunderstood as a psychological issue or ...

After a long deliberation, a special committee at NICE has decided that Soliris (eculizumab) should be used for patients with atypical haemolytic uraemic syndrome (aHUS), a life-threatening ...

The patents surrounding Soliris (eculizumab) extend its period of market exclusivity from 2022 to 2027, but Alexion thinks it has found a chink in the legal armour. Soliris is still the mainstay ...

In both of these trials, the efficacy and safety associated with zaltenibart monotherapy will be compared to those associated with eculizumab or ravulizumab. According to Gregory A. Demopulos, MD, ...

Neurology experts from UCSF Health presented new clinical research findings and cutting-edge treatment strategies and received distinguished awards recognition at the American Academy of Neurology’s ...

At close: 5:24:33 PM GMT+3 ...